Spearheading End-to-End mRNA Therapeutic Development by Optimising Formulation & Delivery, De-Risking the Path to Clinic & Enhancing Manufacturing & Analytical Strategies to Realize the Full Potential of mRNA Medicines
The mRNA therapeutics and LNP delivery landscapes are entering a new era of clinical ambition, technological innovation and strategic investment. From Moderna and Merck's Phase III progress in personalised mRNA cancer vaccines, to Eli Lilly's collaboration with METiS TechBio on tissue-targeted LNPs, momentum is building beyond conventional vaccine applications. Yet unlocking mRNA's therapeutic potential depends on optimising mRNA expression and durability, achieving targeted extrahepatic delivery and overcoming the analytical and manufacturing challenges of clinical development.
For 2027, the 6th mRNA-Based Therapeutics & Non-Viral Delivery Summit Europe unites three established conferences into one integrated meeting. Bringing together the mRNA-Based Therapeutics, Lipid Nanoparticles Development and mRNA Process Development & CMC communities, the expanded summit connects RNA design, delivery innovation and manufacturing expertise to tackle challenges across the development pathway.
Across two specialist content streams, R&D & Preclinical Development and Process Development & CMC, explore:
Past attendees:
I really enjoyed the event. The engaging talks and the variety of speakers from across the globe truly stood out, offering diverse perspectives and insightful discussions on mRNA therapeutics. The location was very nice as well in Berlin. A great setting for networking and learning. Overall, it was a well-organized experience that felt both energizing and meaningful.
Senior Scientist, AstraZeneca
Past attendees:
The speaker lineup was excellent, with a strong balance between academic leaders and industry experts
Chief Business Officer & CMC Lead, CybernaX Bio
2027 speakers:
Innovation thrives when diverse expertise comes together. By uniting the mRNA and non-viral delivery community, this meeting provides a unique platform to share knowledge, identify common challenges, and leverage synergies across different modalities. These interactions can spark new ideas, strengthen collaborations, and ultimately accelerate the translation of scientific innovation into meaningful patient impact
Associate Director GMP/CMC Drug Product, BioNTech
RNA Engineering:
Optimising translation, expression durability and immune activation across mRNA, circRNA and xRNA.
Targeted Non-Viral Delivery:
Advancing ionisable lipids, targeted LNPs, endosomal escape and extrahepatic delivery.
Therapeutic Applications:
Exploring in vivo CAR-T, gene editing, oncology, respiratory and cardiometabolic therapies.
RNA & LNP Manufacturing:
Improving RNA purity, circRNA recovery, LNP formulation and scalable production.
Analytical & CMC Strategies:
Strengthening potency assays, product characterisation, stability and GMP readiness.
AI & Automation:
Accelerating lipid discovery, RNA screening and automated DNA-to-mRNA workflows.
Join 28+ expert speakers from AstraZeneca, BioNTech, Sanofi, Abogen, NeoVac and more in Berlin on 18–19 February 2027 to discover emerging data, benchmark development strategies and connect with potential partners advancing the next generation of RNA medicines.
Explore the Full Event Guide
Discover what's bringing Europe's RNA therapeutics, non-viral delivery and CMC communities together in Berlin.
- 28+ Expert Speakers
Hear from AstraZeneca, BioNTech, Sanofi, Abogen and emerging RNA innovators - 2 Specialist Content Streams
Dive into R&D & Preclinical Development or Process Development & CMC, with shared plenaries bridging both - 3 Established Conferences United
Connecting mRNA therapeutics, lipid nanoparticle development and mRNA manufacturing in one summit - 6+ Therapeutic Areas Explored
From oncology and genetic diseases to respiratory, cardiometabolic, autoimmune and ocular applications
Official Partners
Lead Partner
Expertise Partners
Exhibition Partners
Innovation Partner
Attending Companies Include
Explore Related Events
Explore the Agenda
Discover the latest advances in RNA therapeutics, targeted non-viral delivery and mRNA manufacturing, from tissue-specific LNPs and emerging RNA modalities to GMP-ready processes.
Partner With Us
Showcase your RNA technologies, delivery platforms and manufacturing solutions to biopharma decision-makers seeking partners to overcome critical development challenges.
Join Biopharma Experts
Connect with Europe's therapeutic R&D, non-viral delivery and CMC experts in one integrated summit, bringing together the teams advancing next-generation mRNA medicines towards the clinic.